Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Botulinum a toxin/dimethyl sulfoxide bladder instillations for women with refractory idiopathic detrusor overactivity: a phase 1/2 study.

Petrou SP, Parker AS, Crook JE, Rogers A, Metz-Kudashick D, Thiel DD.

Mayo Clin Proc. 2009 Aug;84(8):702-6. doi: 10.1016/S0025-6196(11)60520-X.

PMID:
19648387
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Botulinum toxin a versus placebo for refractory detrusor overactivity in women: a randomised blinded placebo-controlled trial of 240 women (the RELAX study).

Tincello DG, Kenyon S, Abrams KR, Mayne C, Toozs-Hobson P, Taylor D, Slack M.

Eur Urol. 2012 Sep;62(3):507-14. doi: 10.1016/j.eururo.2011.12.056. Epub 2012 Jan 5.

PMID:
22236796
[PubMed - indexed for MEDLINE]
3.

Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity.

Gamé X, Khan S, Panicker JN, Kalsi V, Dalton C, Elneil S, Hamid R, Dasgupta P, Fowler CJ.

BJU Int. 2011 Jun;107(11):1786-92. doi: 10.1111/j.1464-410X.2010.09791.x. Epub 2010 Oct 29.

PMID:
21040367
[PubMed - indexed for MEDLINE]
4.

OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.

Nitti VW, Dmochowski R, Herschorn S, Sand P, Thompson C, Nardo C, Yan X, Haag-Molkenteller C; EMBARK Study Group.

J Urol. 2013 Jun;189(6):2186-93. doi: 10.1016/j.juro.2012.12.022. Epub 2012 Dec 14.

PMID:
23246476
[PubMed - indexed for MEDLINE]
5.

Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity.

Kanagarajah P, Ayyathurai R, Caruso DJ, Gomez C, Gousse AE.

Int Urol Nephrol. 2012 Feb;44(1):91-7. doi: 10.1007/s11255-011-9979-9. Epub 2011 Jun 4.

PMID:
21643644
[PubMed - indexed for MEDLINE]
6.
7.

Reduction of urgency severity is associated with long-term therapeutic effect after intravesical onabotulinumtoxin A injection for idiopathic detrusor overactivity.

Kuo HC.

Neurourol Urodyn. 2011 Nov;30(8):1497-502. doi: 10.1002/nau.21132. Epub 2011 Jun 29.

PMID:
21717501
[PubMed - indexed for MEDLINE]
8.

Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.

Ghei M, Maraj BH, Miller R, Nathan S, O'Sullivan C, Fowler CJ, Shah PJ, Malone-Lee J.

J Urol. 2005 Nov;174(5):1873-7; discussion 1877.

PMID:
16217327
[PubMed - indexed for MEDLINE]
9.

Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics.

Kuo HC.

Neurourol Urodyn. 2011 Sep;30(7):1242-8. doi: 10.1002/nau.21054. Epub 2011 May 10.

PMID:
21560152
[PubMed - indexed for MEDLINE]
10.

Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity.

Kuo HC.

J Urol. 2007 Oct;178(4 Pt 1):1359-63. Epub 2007 Aug 16.

PMID:
17706718
[PubMed - indexed for MEDLINE]
11.

A comparison between the response of patients with idiopathic detrusor overactivity and neurogenic detrusor overactivity to the first intradetrusor injection of botulinum-A toxin.

Popat R, Apostolidis A, Kalsi V, Gonzales G, Fowler CJ, Dasgupta P.

J Urol. 2005 Sep;174(3):984-9.

PMID:
16094019
[PubMed - indexed for MEDLINE]
13.

Is efficacy of repeated intradetrusor botulinum toxin type A (Dysport) injections dose dependent? Clinical and urodynamic results after four injections in patients with drug-resistant neurogenic detrusor overactivity.

Ghalayini IF, Al-Ghazo MA, Elnasser ZA.

Int Urol Nephrol. 2009 Dec;41(4):805-13. doi: 10.1007/s11255-009-9528-y. Epub 2009 Jan 31.

PMID:
19184509
[PubMed - indexed for MEDLINE]
14.

Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.

Giannantoni A, Rossi A, Mearini E, Del Zingaro M, Porena M, Berardelli A.

J Urol. 2009 Oct;182(4):1453-7. doi: 10.1016/j.juro.2009.06.023. Epub 2009 Aug 15.

PMID:
19683298
[PubMed - indexed for MEDLINE]
15.

Videourodynamic changes of botulinum toxin A in patients with neurogenic bladder dysfunction (NBD) and idiopathic detrusor overactivity (IDO) refractory to drug treatment.

Alloussi SH, Lang Ch, Eichel R, Al-Kaabneh A, Seibold J, Schwentner C, Alloussi S.

World J Urol. 2012 Jun;30(3):367-73. doi: 10.1007/s00345-011-0736-6. Epub 2011 Aug 13.

PMID:
21842216
[PubMed - indexed for MEDLINE]
16.

Repeated botulinum toxin type A injections for refractory overactive bladder: medium-term outcomes, safety profile, and discontinuation rates.

Dowson C, Watkins J, Khan MS, Dasgupta P, Sahai A.

Eur Urol. 2012 Apr;61(4):834-9. doi: 10.1016/j.eururo.2011.12.011. Epub 2011 Dec 13.

PMID:
22204745
[PubMed - indexed for MEDLINE]
17.

Intravesical instillation of botulinum toxin A: an in vivo murine study and pilot clinical trial.

Krhut J, Zvara P.

Int Urol Nephrol. 2011 Jun;43(2):337-43. doi: 10.1007/s11255-010-9790-z. Epub 2010 Jun 20.

PMID:
20563845
[PubMed - indexed for MEDLINE]
18.

Intravesical botulinum type-A toxin (Dysport®) in the treatment of idiopathic detrusor overactivity in children.

Blackburn SC, Jones C, Bedoya S, Steinbrecher HA, Malone PS, Griffin SJ.

J Pediatr Urol. 2013 Dec;9(6 Pt A):750-3. doi: 10.1016/j.jpurol.2012.08.011. Epub 2012 Oct 1.

PMID:
23036518
[PubMed - indexed for MEDLINE]
19.

Urodynamic assessment of children treated with botulinum toxin A injections for urge incontinence: a pilot study.

Lahdes-Vasama TT, Anttila A, Wahl E, Taskinen S.

Scand J Urol Nephrol. 2011 Dec;45(6):397-400. doi: 10.3109/00365599.2011.590997. Epub 2011 Jul 8.

PMID:
21740110
[PubMed - indexed for MEDLINE]
20.

Botulinum toxin treatment for bladder dysfunction.

Santos-Silva A, da Silva CM, Cruz F.

Int J Urol. 2013 Oct;20(10):956-62. doi: 10.1111/iju.12188. Epub 2013 May 2. Review.

PMID:
23634720
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk